Hernandez, Adan
Tan, Chunfeng
Plattner, Florian
Logsdon, Aric F.
Pozo, Karine
Yousuf, Mohammad A.
Singh, Tanvir
Turner, Ryan C.
Lucke-Wold, Brandon P.
Huber, Jason D.
Rosen, Charles L.
Bibb, James A.
Funding for this research was provided by:
National Institute of Mental Health (MH083711)
National Institute on Drug Abuse (DA033485)
National Institute of Neurological Disorders and Stroke (NS073855)
Darrell K Royal Fund for Alzheimer's Disease (n/A)
American Foundation for Pharmaceutical Education (n/a, n/a)
American Association for Pharmaceutical Scientists (n/a)
Article History
Received: 21 August 2018
Accepted: 16 October 2018
First Online: 9 November 2018
Change Date: 10 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13041-021-00872-w
Ethics approval
: All animal care and experimental studies were approved by the Institutional Animal Care and Use Committees (IACUC) of West Virginia University and UT Southwestern Medical Center, and were performed according to the principles of the <i>Guide for the Care and Use of Laboratory Animals</i>.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.